Tradestie Institutional Equity Comparison Engine

SGMT vs VNDA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGMT Overall Edge

SGMT Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sagimet Biosciences Inc. Series A Common Stock (SGMT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VNDA counters with relative strength in Valuation. Fundamentally, SGMT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, SGMT sits in BREAKOUT (5th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VNDA
SGMT N/M vs VNDA 103.1x Fwd P/E
Growth & Margin Winner SGMT
Op Margin 0.0% vs -77.6% ยท YoY +0.0% vs +24.1%
Momentum & Technical Winner SGMT
1Y +33.0% vs -12.6% ยท 52W Pos 83% vs 4%
Options & Structure Winner SGMT
BREAKOUT (5th %ile IV) vs BREAKDOWN (75th %ile IV)
SGMT NASDAQ
Sagimet Biosciences Inc. Series A Common Stock
Pharmaceutical Preparations
$10.29
+0.68% 1D
Market Cap $775.0M
1M Return +28.3%
1Y Return +32.95%
Forward P/E N/M
Unified AI Score
43.1 / 100 HOLD
Tech 15.0 Fund 46.0 Flow 70.0 Mom 60.0
VNDA NASDAQ
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations
$3.79
-4.89% 1D
Market Cap $238.9M
1M Return -5.83%
1Y Return -12.56%
Forward P/E 103.1x
Unified AI Score
49.0 / 100 HOLD
Tech 56.0 Fund 58.0 Flow 65.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SGMT +32.95% VNDA -12.56% Spread: +45.51 pp (SGMT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SGMT Revenue VNDA Revenue SGMT Op. Margin VNDA Op. Margin Margin Edge
FY2018 N/A $190M N/A 11.3% VNDA
FY2019 N/A $230M N/A 10.0% VNDA
FY2020 N/A $250M N/A 11.0% VNDA
FY2021 N/A $270M N/A 15.7% VNDA
FY2022 N/A $250M N/A 2.5% VNDA
FY2023 $0M $190M -1537.0% -7.2% VNDA
FY2024 N/A $200M N/A -20.5% VNDA
FY2025 N/A $220M N/A -70.0% VNDA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SGMT (5) vs VNDA (5)
Institutional Metric SGMT VNDA Criterion Row Winner
Market Capitalization Scale $775.0M $238.9M Larger Scale SGMT
Trailing P/E Ratio Valuation N/M 103.1x Lower Multiple VNDA
Forward P/E Ratio Valuation N/M 103.1x Lower Multiple VNDA
Revenue Growth (YoY) Growth +0.0% +24.1% Higher Growth VNDA
Operating Margin (TTM) Profitability 0.0% -77.6% Higher Margin SGMT
Net Profit Margin Profitability 0.0% -119.9% Higher Margin SGMT
Return on Equity (ROE) Capital Efficiency -24.4% -82.5% Higher ROE SGMT
52-Week Range Position Momentum 83% ($4โ€“$11) 4% ($4โ€“$10) Stronger Trend SGMT
Beta / 30D Volatility Risk Regime 2.05ฮฒ ยท 84% Vol 1.25ฮฒ ยท 61% Vol Lower Realized Risk VNDA
Unified Institutional Score Composite Signal 43.1 / 100 (HOLD) 49.0 / 100 (HOLD) Higher Composite VNDA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SGMT vs VNDA Buy Guide
SGMT BREAKOUT
140d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SGMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VNDA BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 75th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live VNDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SGMT nor VNDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.